Skip to main content

Table 1 Basic characteristics of selected patients

From: Influence of strengthened hemoperfusion combined with continuous venovenous hemofiltration on prognosis of patients with acute paraquat poisoning: SHP + CVVH improve prognosis of acute PQ patients

Indexes control (n = 98) HP (n = 67) CVVH (n = 59) SHP (n = 135) SHP + CVVH (n = 128) P
Age (years) 35.88 ± 15.77 38.93 ± 14.34 32.41 ± 16.02 33.27 ± 13.03 35.97 ± 14.08 0.61
Male, n (%) 43(43.88%) 27(40.30%) 25(42.37%) 56(41.48%) 54(42.19%) 0.993
Body mass index 23.07 ± 4.10 22.31 ± 5.22 24.13 ± 3.30 23.94 ± 4.07 22.01 ± 5.44 0.39
Number of people with oral poisoning, n (%) 89(90.82) 61(91.04) 53(89.83) 113(91.11) 117(91.41) 0.263
Time from poisoning to treatment (h) 7.03 ± 3.47 6.54 ± 4.05 7.19 ± 3.71 6.35 ± 3.09 6.73 ± 3.41 0.17
Time from poisoning to gastric lavage (h) 4.49 ± 1.31 4.08 ± 1.72 4.45 ± 1.14 4.37 ± 1.38 4.19 ± 1.49 0.871
Time from poisoning to hemoperfusion (h)   9.12 ± 2.36   8.96 ± 2.59 9.02 ± 2.75 0.89
Acute kidney injury, n (%) 26(26.53%) 15(22.39%) 14(23.73%) 32(23.37%) 35(27.34%) 0.923
BUN(mmol/L) 7.33 ± 5.08 7.21 ± 5.14 7.47 ± 4.89 7.41 ± 4.73 7.50 ± 4.55 0.94
CREA (μmol/L) 129.00 ± 98.52 127.91 ± 91.55 133.04 ± 87.05 136.34 ± 90.34 134.51 ± 92.74 0.77
AST (IU/L) 79.04 ± 52.8 78.13 ± 61.77 79.26 ± 50.41 77.45 ± 54.73 78.24 ± 57.49 0.59
ALT (IU/L) 90.74 ± 57.82 88.30 ± 61.37 91.04 ± 53.33 88.21 ± 60.32 89.36 ± 55.82 0.74
Respiratory failure, n(%) 13(13.27%) 7(10.45%) 6(10.17%) 19(14.07) 21(16.41%) 0.726
Arterial blood gas analysis
 PH 7.38 ± 0.14 7.31 ± 0.17 7.40 ± 0.11 7.35 ± 0.18 7.42 ± 0.17 0.83
 PO2 (mmHg) 84.05 ± 19.44 83.42 ± 18.79 83.14 ± 16.94 85.74 ± 17.03 83.97 ± 17.28 0.74
 PCO2 (mmHg) 26.63 ± 11.05 26.08 ± 12.07 29.15 ± 10.85 27.46 ± 11.33 27.04 ± 13.01 0.80
  1. All clinical data were collected at the time of admission